RecruitingNot ApplicableNCT04722341

Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators


Sponsor

Cedars-Sinai Medical Center

Enrollment

175 participants

Start Date

Jan 1, 2022

Study Type

INTERVENTIONAL

Summary

The purpose of this study is to test whether the timing of meals can improve treatment adverse events, influence tumor biology and alter a person's mood and behaviors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study examines whether time-restricted eating — limiting food intake to a specific window of hours each day — improves outcomes and reduces side effects in patients with rectal or breast cancer receiving chemotherapy before surgery. **You may be eligible if:** - You are 18 or older - You have stage II, III, or IV rectal cancer (with curative intent) or HER2-positive or triple-negative breast cancer (stage I–III) - You are currently receiving chemotherapy (neoadjuvant therapy) before surgery and have been on it for no more than 4 weeks - Your BMI is 18.5 or higher **You may NOT be eligible if:** - You have had prior pelvic radiation or prior chemotherapy within 12 months of this cancer diagnosis - You currently eat within a window of less than 10 hours per day (you're already doing it) - You work overnight shifts more than once a week - You are pregnant or breastfeeding - You have serious heart failure, severe neuropathy, or GI problems unrelated to cancer - You have psychiatric or substance use disorders that would interfere with following the eating schedule Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTime-Restricted Eating (TRE)

8-hour daily eating period, starting 1-3 hours after waking up

BEHAVIORALControl

More than equal to a 12-hour daily eating period


Locations(2)

The University of Alabama at Birmingham

Birmingham, Alabama, United States

Cedars-Sinai Medical Center

West Hollywood, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04722341